A pooled analysis of 3 large multicenter trials confirms a survival advantage for NPM1 mut AML in MRD neg remission after intensive induction

Döhner, Konstanze, Döhner, Hartmut, Späth, Daniela, Kapp‐Schwoerer, Silke, Gilkes, Amanda, Thomas, Ian, Johnson, Sean, Potter, Nicola, Bevan, Yana, Othman, Jad, Russell, Nigel H., Röllig, Christoph, Thiede, Christian, Bornhäuser, Martin, Oellerich, Thomas, Hood, Tressa, Elder, Jenna, Carvajal, Luis A., DiMartino, Jorge and Dillon, Richard 2025. A pooled analysis of 3 large multicenter trials confirms a survival advantage for NPM1 mut AML in MRD neg remission after intensive induction. HemaSphere 9 (8) , e70198. 10.1002/hem3.70198

PDF - Published Version Download (728kB)

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine Research Institutes & Centres > Centre for Trials Research (CNTRR)
Additional Information:	License information from Publisher: LICENSE 1: URL: http://creativecommons.org/licenses/by/4.0/
Publisher:	Wiley
ISSN:	2572-9241
Date of First Compliant Deposit:	26 August 2025
Date of Acceptance:	21 July 2025
Last Modified:	26 Aug 2025 15:45
URI:	https://orca.cardiff.ac.uk/id/eprint/180673

Actions (repository staff only)

Edit Item